CN
Mobile Site
Search
Sunshine and health are two important elements in a high-quality life. Linuo Group, Wspecializing in ith solar power and healthcare branches industriesas its two development priorities, Linuo Group has been striving to develop itself steadily and to build a life of high quality for all peopleus all.
We will bring you the latest news. We may be separated by oceans and landmasses, but we share the fate of our planet. What happens in China, even in one corporation like Linuo Group, is relevant to all of us in one global marketplace and in one natural environment.
Linuo Group is a meeting of subsidiaries in several fast-growing sectors, but more importantly, is an integration of several historic companies, some a century old, with newly established high tech companies. This is probably a unique combination in China, inspiring all Linuo team members with tradition and innovation, while creating a special and respected brand.
Constant innovation is a key driver of corporate growth. Linuo Group places great emphasis on innovation in all areas of production, service, management and marketing. We are here to meet the needs of consumers in the new era and ceaseless innovation is crucial.
Linuo Group companies have taken quite different paths to lead them to the present day. Some are more than a century old, not something that can be said about many Chinese enterprises today, while others are newly founded high-tech companies. This makes for an interesting and mutually inspiring mix of Group members, contributing to a deep and meaningful Linuo brand.
· Do you want to design a better future?
· Then Linuo Group is for you!
Shandong Hongjitang Pharmaceutical Group Co., Ltd. was founded in 1907. It is a nationally-known Traditional Chinese Medicine (TCM) company, ranking in the top 50 in China’s TCM industry. Hongjitang has 148 TCM medical product approval numbers and 11 large formulations, giving it a competitive edge.
In 1915, Hongjitang Ejiao won the gold medal at the Panama Pacific International Exposition, which was the first award bestowed upon TCM and TCM health care products in the world. In 2015, the same product won another award at the Milan World Expo, and Hongjitang’s project developing and industrializing synthetic muscone won China’s First Class National Award for Science and Technology Progress.
Technological superiority:
Hongjitang’s world-class TCM production facilities have been built according to the latest cGMP standards. Procedures like extraction, pulverizing and air conditioners are automated, while using elevated warehouses, unique electronic supervision ID coding and a professional logistics delivery system. Our synthetic muscone production is fully automated. To ensure the source and quality of our key raw material for Ejiao, we have initiated DNA testing for every piece of donkey skin used to produce Ejiao, with relevant information retrieved by scanning its QR code.
Innovation:
Hongjitang Group is a national high-tech enterprise. Its facilities include a provincial enterprise technology center, a TCM oral dosage laboratory, a TCM quality control laboratory, a post-doctoral innovation training base and other provincial research and innovation platforms. In recent years, Hongjitang ndw drug manufacturing approvals include: two TCM Category VI, a number of TCM Category VIII and IX, and two Chemical Medicine Category VI. Among its products, two have obtained a TCM Protection Certificate and three others have become standards in the Pharmacopoeia of PRC.
Brand:
Hongjitang Pharmaceutical serves in the Vice-President role in the China Association of Traditional Chinese Medicine, China Health Care Association, Shandong Pharmaceutical Industry Association, Shandong Ejiao Industry Association, and Jinan Chemical and Pharmaceutical Industry Association. Hongjitang is recognized as a Chinese Time-Honoured Brand, and the TCM Culture of Hongjitang is listed in the Intangible Cultural Heritage Directory of Shandong Province. Hongjitang TCM Park is an ecological tourism centre, integrating modern TCM production, TCM culture, leisure and recreation, industrial tourism, and film and video shooting.
In September 2016, Hongjitang (Stock Code: 838658) entered the capital market and went public on NEEQ, signifying its transformation from a traditional manufacturer to an innovation-driven enterprise. With TCM as one of the drivers of the national economy, Hongjitang Pharmaceutical plans to become the No.1 mass-market brand in the TCM industry within the coming years. It will also cooperate with domestic peer enterprises and overseas industry leaders to develop into new areas and markets, always dedicated to the healthcare of humanity.